Introduction
Posttraumatic stress disorder (PTSD) includes symptoms of intrusions, avoidance, negative alterations in cognition and mood (NACM), and hyperarousal, and is highly associated with negative emotions, (e.g., anger, negative behaviors; Renshaw and Kiddie, 2012) . Most studies examining PTSD and anger have not differentiated between internal and external expressions of anger. Furthermore, there is a dearth of research investigating specific PTSD symptoms clusters' effects on internal and external anger expression. Chemtob et al. (1997) postulate individuals with PTSD view external stimuli as threatening (even if they are neutral), leading an individual to react with physiological arousal and anger, which can lead to negative behaviors. Alternatively, fear avoidance theory (Foa et al., 1995) posits anger functions as an avoidant coping mechanism; specifically, an individual faced with trauma-related stimuli will react with anger to avoid dealing with fear, leading to ineffective emotional processing and increased chances of engaging in problematic behavior secondary to their internal anger experience. To our knowledge, one study (examining combat veterans) examined PTSD's direct and indirect effects on negative behaviors (e.g., aggression) utilizing anger as a mediator (Renshaw and Kiddie, 2012) . This study suggested PTSD symptoms elicit internal feelings of anger, which lead to heightened levels of negative overt behavior.
In this study, Gross and John's (1997) emotion-generative model comprises three domains: impulse strength (the degree one responds internally to an emotional stimulus), and positive or negative expressivity (how strongly positive/negative behavior is conveyed in response to a positive or negative emotion, respectively).
Theoretically, when considering negative expressivity and Chemtob et al.'s (1997) model, individuals with PTSD should perceive trauma-related stimuli or intrusive symptoms as threatening, heightening hyperarousal symptoms and anger. Anger secondary to PTSD may lead to increased negative expressivity. Considering fear avoidance theory (Foa et al., 1995) and negative expressivity, individuals with more avoidance may react with anger to avoid fear associated with intrusive stimuli (or PTSD's intrusive symptoms), resulting in heightened negative expressivity. We hypothesize: 1) PTSD's hyperarousal, avoidance, and intrusions clusters will be associated with heightened negative expressivity, and 2) anger will mediate this relationship.
Method

Participants and Procedures
This study was approved by a Midwestern U.S. university's Institutional Review Board.
Trained staff received informed consent from 117 individuals seeking mental healthcare at a community mental health center in the Midwestern U.S. Our sample was restricted to those endorsing prior trauma exposure (N = 57), composed of the following demographics: female, (n = 39; 68%), age 18-71 years old (M = 35.29, SD = 12.25), Caucasian (n = 52; 91%), married (35%; n = 19) or single (31%; n = 17), and having high school education or less (42%; n =23), or at least some college (57%; n = 32).
Measures
The 13-item Stressful Life Events Screening Questionnaire (SLESQ; Goodman et al., 1998) , assessed lifetime traumatic event exposure on a "yes" or "no" response scale. The SLESQ has shown good overall test-retest reliability (0.89), and concurrent and convergent validity (Goodman et al., 1998) . Participants indicated their most distressing event, and rated symptoms using the PTSD Checklist for DSM-5.
The 20-item PTSD Checklist for DSM-5 (PCL-5; Weathers et al., 2013 ) was used to assess PTSD symptoms. The PCL-5 has a 5-point scale ranging from 0 to 4. The initial PCL demonstrated good reliability (α =0.94; test-retest r =0.88). In this study, internal consistency was excellent (α = 0.97).
The 16-item Berkeley Expressivity Questionnaire (BEQ; Gross and John, 1997 ) assessed dimensions of emotional expression. We focused on the negative expressivity subscale (BEQ-N), which is comprised of 6 items. The measure has a 7-point scale from 1 to 7. Internal consistency, test-retest reliability, and convergent and discriminant validity of the BEQ are adequate to excellent (Gross and John, 1997) . In this study, BEQ-N showed adequate internal consistency (α = 0.70).
The 5-item Dimensions of Anger Reaction Scale -5 (DAR-5; Forbes et al., 2014 ) was used to measure anger reactions in response to stress. The DAR-5 has a 5-point scale from 1 to 5 and good internal consistency (α = 0.89), and good convergent and discriminant validity (Forbes et al., 2014) . In this study, internal consistency was excellent (α = 0.91).
Data Analysis
Two participants were excluded due to incomplete study measures (n = 55). Missing data were estimated using maximum likelihood estimation. All variables were normally distributed, and were non-collinear. All correlations between variables are presented in Table 1 . Multiple regression was completed to assess which PTSD symptom cluster most strongly predicted negative expressivity. One regression was computed with all four PTSD symptom clusters entered simultaneously as predictors. Regressions controlled for the associations between PTSD factors. Negative expressivity was the dependent variable. After finding significant direct effects, we used the PROCESS SPSS macro for Model 4 (see Hayes, 2013) to assess for anger as a mediator.
Results
Regression results (see Figure 1) 
Discussion
Although hypotheses were partially confirmed in that individuals with heightened avoidance endorsed higher levels of negative expressivity, anger did not mediate this relationship; however, Foa et al. (1995) posit that anger is an avoidant reaction to fear associated with traumatic stimuli. Anger may merely be an extension of, rather than a direct reaction to, PTSD's avoidance symptoms (hence, lack of a mediating effect).
The large effect size for lowered intrusions resulting in heightened negative expressivity through anger's mediation is surprising; however, we are unsure of the temporal relations between the experience of PTSD symptoms and participants' identified trauma. Therefore, if a person experiences initial levels of intrusion symptoms following a trauma, s/he could experience more severe anger reactions due to the recent nature of the trauma, leading to more overt expressions of negative behavior. Future longitudinal work could tease apart the temporal relationship between these constructs.
The lack of hyperarousal symptoms' effects on negative expressivity could have been impacted by our sample size, because hyperarousal in past research has related to anger and aggression (e.g., Dewey et al., 2014) .
This study carries clinical implications. Specifically, PTSD's intrusive symptoms indirect effect on negative expressivity through anger suggests that implementation of anger management protocols into PTSD-focused treatments could be helpful. The major strength of our study is that it is one of few examining specific DSM-5 PTSD symptom clusters' relationships with internal anger and expression of negative behaviors in response to anger in a civilian treatment-seeking sample.
Limitations include: reliance on self-report data, assessment of negative expressivity rather than behaviors specific to anger (e.g., violence), the study's small sample size, and the cross-sectional nature of data did not allow for causal inference. Future research addressing the limitations is needed to further understand the relationship between PTSD, anger, and emotion expression.
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